Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Pharmaceutical Investing
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 2 DATA FOR INVESTIGATIONAL OLPASIRAN IN ADULTS WITH ELEVATED LIPOPROTEIN Market News
LAWSUITS FILED AGAINST ABBV, SDIG and AUPH - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SDIG, AUPH and UPST Pharmaceutical Investing
SHAREHOLDER ALERT: VLTA ABBV LILM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Class Action Lawsuit and Urges Investors with Substantial Losses to Contact the Firm Pharmaceutical Investing
CLASS ACTION UPDATE for MYPS, AUPH and LILM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
